Ocugen Inc (OCGN)
0.7182
-0.02
(-2.96%)
USD |
NASDAQ |
Dec 24, 16:00
Ocugen Cash from Investing (Quarterly): -0.507M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cytokinetics Inc | -45.05M |
| enVVeno Medical Corp | 6.22M |
| Scholar Rock Holding Corp | 35.31M |
| Mirum Pharmaceuticals Inc | -18.04M |
| MetaVia Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.27M |
| Cash from Financing (Quarterly) | 34.79M |
| Free Cash Flow | -49.17M |
| Free Cash Flow Per Share (Quarterly) | -0.0423 |
| Free Cash Flow to Equity (Quarterly) | -11.81M |
| Free Cash Flow Yield | -26.10% |